Large-scale literature mining to assess the relation between anti-cancer drugs and cancer types

Chris Bauer1, Ralf Herwig2, Matthias Lienhard2

  • 1MicroDiscovery GmbH, Marienburger Straße 1, 10405, Berlin, Germany. chris.bauer@microdiscovery.de.

Abstract

Insights

Automated text mining effectively identifies relationships between cancer types and anti-cancer drugs. Validation confirms accuracy, offering a web-based knowledge base for novel drug discovery and research.

Area of Science:

  • Oncology
  • Computational Biology
  • Bioinformatics

Background:

  • Vast scientific literature details tumor types and anti-cancer drug relationships.
  • Manual information extraction is infeasible for researchers and physicians.
  • Need for automated methods to analyze extensive cancer-drug literature.

Purpose of the Study:

  • To apply automated text mining for assessing relationships between 30 cancer types and 270 anti-cancer drugs.
  • To validate text mining results using independent data sources.
  • To create an accessible knowledge base for cancer-drug research.

Main Methods:

  • Utilized classical text mining (named entity recognition) and AI (word embeddings).
  • Assessed relationships between 30 frequent cancer types and 270 anti-cancer drugs.
  • Validated findings with FDA approvals, IC-50 cell line data, and clinical patient survival data.

Main Results:

  • Automated text mining successfully identified cancer-drug relationships.
  • Validation methods confirmed good correspondence between literature mining and independent data.
  • Results visualized in a heatmap and accessible via an interactive web-based knowledge base.

Conclusions:

  • Automated approach efficiently assesses compound-cancer type relationships.
  • Cancer types and compounds can be clustered, aiding research.
  • Interactive knowledge base supports novel indication area identification for drugs.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
486
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.9K